FDA approves first biosimilar productMarch 9, 2015AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyTransplantationAML
‘Biodegradable’ CAR may aid transplant in AMLMarch 6, 2015Leukemia, Myelodysplasia, TransplantationTransplantationAML
FDA puts drug on fast track to treat secondary AMLJanuary 22, 2015Leukemia, Myelodysplasia, TransplantationPharmacyAML
Drug can increase survival in poor-risk AMLJanuary 14, 2015Leukemia, Myelodysplasia, TransplantationAML
Study reveals potential strategy to treat AMLJanuary 13, 2015Leukemia, Myelodysplasia, TransplantationAML
Certain cancers primarily result from ‘bad luck’January 3, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated IssuesAMLNon-Hodgkin Lymphoma
Study confirms IDH2 as therapeutic target in AML, MDSDecember 18, 2014Leukemia, Myelodysplasia, TransplantationAML
Discovery could help predict, prevent therapy-related AMLDecember 12, 2014Leukemia, Myelodysplasia, TransplantationAML
First randomized evidence for kinase inhibitor use in AMLDecember 11, 2014Leukemia, Myelodysplasia, TransplantationAML
More isn’t always better with daunorubicin induction in AMLDecember 10, 2014Leukemia, Myelodysplasia, TransplantationAML
CLL drug can fight AML too, study suggestsDecember 10, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAML
Finding could help docs tailor treatment for myeloid leukemiasDecember 9, 2014Leukemia, Myelodysplasia, TransplantationAMLCML
Breast cancer drug could treat MPNs, AMLDecember 5, 2014CythemiasLeukemia, Myelodysplasia, TransplantationAML
FDA grants drug orphan designation for AMLDecember 3, 2014Leukemia, Myelodysplasia, TransplantationPharmacyAML
Targeting enzyme can eliminate CSCs in AMLDecember 2, 2014Leukemia, Myelodysplasia, TransplantationAML